Literature DB >> 20524083

Synchronous occurrence of neuroendocrine colon carcinoma and hairy cell leukemia.

Nikolaos S Salemis1, Dionisios Pinialidis, Evangelos Tsiambas, Christos Gakis, Georgios Nakos, Dimitrios Sambaziotis, Charalambos Christofyllakis.   

Abstract

UNLABELLED: BACKGROUND-
PURPOSE: The risk of secondary malignancy development in patients with hairy cell leukemia has been evaluated in several studies with varying results. The aim of this study is to describe a case of synchronous occurrence of neuroendocrine colon carcinoma and hairy cell leukemia.
METHODS: A 69-year-old man presented with rectal bleeding. Colonoscopy revealed a rectal tumor, whereas biopsy specimens revealed a poorly differentiated carcinoma. During the preoperative evaluation, pancytopenia was detected.
RESULTS: At laparotomy, a mass was detected 16 cm from the anal verge and an anterior resection of the rectum was performed. Detailed histological and immunohistochemical analyses revealed a poorly differentiated neuroendocrine carcinoma of the rectum. Postoperative evaluation of pancytopenia revealed hairy cell leukemia. The patient was initially treated with chemotherapy for hairy cell leukemia followed by chemotherapy for neuroendocrine colon carcinoma. Survival was 44 months.
CONCLUSIONS: To our knowledge, synchronous occurrence of neuroendocrine colon carcinoma and hairy cell leukemia has not been previously reported in the literature. Given the rare incidence of both entities in the general population, it is highly unlikely that they occurred together by chance. Further research is needed to determine what would be the optimal management options of patients with simultaneous hairy cell leukemia and a neuroendocrine colon cancer.

Entities:  

Mesh:

Year:  2011        PMID: 20524083     DOI: 10.1007/s12029-010-9167-7

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  22 in total

1.  Indolent neuroendocrine tumor involving the bone marrow. A case report with a 9-year follow-up.

Authors:  Ellen Schlette; L Jeffrey Medeiros; Miloslav Beran; Carlos E Bueso-Ramos
Journal:  Arch Pathol Lab Med       Date:  2003-04       Impact factor: 5.534

2.  Risk of second cancer in patients with hairy cell leukemia: long-term follow-up.

Authors:  Massimo Federico; Pier Luigi Zinzani; Antonio Frassoldati; Marco Vinceti; Alessia Modè; Luciana Annino; Teodoro Chisesi; Guido Pagnucco; Rosangela Invernizzi; Mauro Spriano; Luigi Resegotti; Maurizio Bendandi; Eugenio E Damasio
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

Review 3.  Clinical presentations and complications of hairy cell leukemia.

Authors:  Mark A Hoffman
Journal:  Hematol Oncol Clin North Am       Date:  2006-10       Impact factor: 3.722

4.  Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.

Authors:  I W Flinn; K J Kopecky; M K Foucar; D Head; J M Bennett; R Hutchison; W Corbett; P Cassileth; T Habermann; H Golomb; K Rai; E Eisenhauer; F Appelbaum; B Cheson; M R Grever
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

Review 5.  Second malignancy in hairy cell leukaemia: no evidence of increased incidence after treatment with interferon alpha.

Authors:  R Pawson; R A'Hern; D Catovsky
Journal:  Leuk Lymphoma       Date:  1996-06

6.  Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia.

Authors:  Rudolf Benz; Raffaele Daniele Siciliano; Georg Stussi; Jörg Fehr
Journal:  Eur J Haematol       Date:  2008-12-05       Impact factor: 2.997

7.  Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment.

Authors:  P Kampmeier; R Spielberger; J Dickstein; R Mick; H Golomb; J W Vardiman
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

8.  Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.

Authors:  Michie Hisada; Bingshu E Chen; Elaine S Jaffe; Lois B Travis
Journal:  J Natl Cancer Inst       Date:  2007-02-07       Impact factor: 13.506

9.  Second malignancies in patients with hairy cell leukemia in british columbia: a 20-year experience.

Authors:  W Y Au; R J Klasa; R Gallagher; N Le; R D Gascoyne; J M Connors
Journal:  Blood       Date:  1998-08-15       Impact factor: 22.113

10.  Second malignancies in hairy cell leukemia.

Authors:  R H Jacobs; E E Vokes; H M Golomb
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

View more
  1 in total

1.  Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality?

Authors:  Rafael Parra-Medina; Paula Moreno-Lucero; Julian Jimenez-Moreno; Alejandra María Parra-Morales; Alfredo Romero-Rojas
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.